Author: Dr Delwyn Dyall-Smith FACD, Dermatologist, 2009.
Heparin-induced skin necrosis is a rare complication of heparin injections either at the injection site or distant sites, in which there is the death of skin cells (necrosis) due to the inadequate blood supply.
Heparin can also give rise to other cutaneous reactions, including:
Heparin necrosis can affect adults receiving subcutaneous or intravenous heparin injections either to treat established deep venous thrombosis (DVT) or to prevent this occurring when they are at risk of developing DVTs, such as following surgery or prolonged hospitalisation. Women appear to be more commonly affected by heparin-induced necrosis than men.
Heparin necrosis begins on average 7 days (range 1–17 days) after starting heparin injections. Redness, pain and swelling under the skin develop at the heparin injection sites. Within hours or 1–2 days blisters develop and then a black-red centre appears due to skin necrosis (death of skin cells). There is surrounding redness and bruising. In many cases, it occurs only at the injection site, but it can develop anywhere on the skin with no apparent preferred sites. Usually, the area of necrosis is only about 3 cm in diameter but can be more extensive.
The diagnosis is usually suspected clinically, but a skin biopsy may be performed. Histopathology shows the death of the surface skin and sometimes clots or inflammation in small blood vessels of the deeper skin.
Blood tests should be done to work out the cause of the heparin reaction and exclude other causes of skin necrosis.
In many cases, heparin necrosis is due to an allergic immune reaction involving a complex of antibody, heparin, platelet factor 4 (PF4) and platelet. This should be tested for as it is important not to have further heparin if it is positive. This form of heparin necrosis is called ‘heparin-induced thrombocytopenia type II’, and, as the name suggests, is associated with low platelet counts.
Heparin necrosis can occur in the absence of these antibodies and the mechanism may then be less clear. Blood tests are also be done for clotting factors, protein C and protein S (which are usually normal).
Subcutaneous provocation tests should not be performed when there has been skin necrosis.
Generally ceasing the heparin injections promptly leads to recovery. Wound care involves cleaning and dressing areas of skin loss, with appropriate pain relief. Sometimes surgery is required to remove the dead skin and a skin graft may be performed if this is extensive, resulting in more prolonged recovery time. If anticoagulation is still required, an alternative drug should be used. This may include aspirin, warfarin, hirudins or unfractionated heparin, depending on the cause of the heparin necrosis. If HIT is excluded, a change in heparin type may be used safely.
Heparin necrosis may rarely be fatal from complications of large areas of skin loss in severe cases or, if heparin is not ceased immediately and replaced by an appropriate anti-coagulant in HIT, due to clots developing internally.
See the DermNet NZ bookstore.
© 2020 DermNet New Zealand Trust.